Avalo Therapeutics Inc (AVTX)
10.84
-0.65
(-5.66%)
USD |
NASDAQ |
May 10, 16:00
10.79
-0.05
(-0.46%)
After-Hours: 18:05
Avalo Therapeutics Enterprise Value: 4.467M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 4.467M |
| May 08, 2024 | 4.715M |
| May 07, 2024 | 6.287M |
| May 06, 2024 | 6.556M |
| May 03, 2024 | 7.435M |
| May 02, 2024 | 8.500M |
| May 01, 2024 | 9.131M |
| April 30, 2024 | 10.29M |
| April 29, 2024 | 10.04M |
| April 26, 2024 | 9.069M |
| April 25, 2024 | 8.076M |
| April 24, 2024 | 7.269M |
| April 23, 2024 | 6.028M |
| April 22, 2024 | 5.211M |
| April 19, 2024 | 4.612M |
| April 18, 2024 | 5.004M |
| April 17, 2024 | 6.669M |
| April 16, 2024 | 9.069M |
| April 15, 2024 | 8.345M |
| April 12, 2024 | 7.993M |
| April 11, 2024 | 8.872M |
| April 10, 2024 | 8.158M |
| April 09, 2024 | 7.559M |
| April 08, 2024 | 7.259M |
| April 05, 2024 | 9.544M |
| Date | Value |
|---|---|
| April 04, 2024 | 9.441M |
| April 03, 2024 | 9.451M |
| April 02, 2024 | 8.262M |
| April 01, 2024 | 11.10M |
| March 28, 2024 | 15.08M |
| March 27, 2024 | -2.503M |
| March 26, 2024 | -3.427M |
| March 25, 2024 | -3.240M |
| March 22, 2024 | -3.206M |
| March 21, 2024 | -3.448M |
| March 20, 2024 | -3.560M |
| March 19, 2024 | -3.663M |
| March 18, 2024 | -3.586M |
| March 15, 2024 | -3.646M |
| March 14, 2024 | -3.406M |
| March 13, 2024 | -2.990M |
| March 12, 2024 | -3.046M |
| March 11, 2024 | -2.909M |
| March 08, 2024 | -2.701M |
| March 07, 2024 | -3.214M |
| March 06, 2024 | -3.270M |
| March 05, 2024 | -3.807M |
| March 04, 2024 | -3.727M |
| March 01, 2024 | -3.872M |
| February 29, 2024 | -3.880M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-4.192M
Minimum
Jan 17 2024
47.26B
Maximum
Dec 24 2019
7.990B
Average
203.59M
Median
Oct 07 2021
Enterprise Value Benchmarks
| Imunon Inc | -1.878M |
| iBio Inc | 16.42M |
| Kodiak Sciences Inc | -85.87M |
| Petros Pharmaceuticals Inc | -0.5067M |
| Ocugen Inc | 390.50M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.168M |
| Revenue (Quarterly) | 0.571M |
| Total Expenses (Quarterly) | 4.322M |
| EPS Diluted (Quarterly) | -10.19 |
| Profit Margin (Quarterly) | -1.43K% |
| Earnings Yield | -3.53K% |
| Normalized Earnings Yield | -3445.79 |